OTC · Financial Statements
Bioasis Technologies Inc. (BIOAF) Financial Statements
$0.00
OTC: BIOAF
Market Cap $7941
Overview Financials Dividend Bioasis Technologies Inc. most recently reported annual revenue of $0, net profit of $-3.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2018 2019 2020 2021 2022 Revenue $1.0M $1.0M $1.0M $4.0M $0 Operating Profit $-5.0M $-6.0M $-5.0M $-1.0M $-5.0M Net Profit $-5.0M $-3.0M $-4.0M $1.0M $-3.0M EPS $-0.10 $-0.06 $-0.07 $0.01 $-0.04 Op Margin -887.6% -438.8% -856.5% -21.0% -12784.5%
Balance Sheet (USD)
Metric 2018 2019 2020 2021 2022 Total Assets $1.0M $2.0M $1.0M $3.0M $2.0M Total Liabilities $1.0M $2.0M $3.0M $3.0M $4.0M Cash $1.0M $1.0M $1.0M $3.0M $2.0M Borrowings $0 $0 $1.0M $0 $2.0M
Cash Flow (USD)
Metric 2018 2019 2020 2021 2022 Operating Cash Flow $-4.0M $-3.0M $-3.0M $2.0M $-4.0M Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $0 $0 $2.0M $1.0M $0 Net Cash Flow $0 $1.0M $-1.0M $2.0M $-1.0M Free Cash Flow $-4.0M $-3.0M $-3.0M $2.0M $-4.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.01 EV / EBITDA -0.16 FCF Yield -915.58% Quick Ratio 0.70 Interest Coverage -7.47 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock